Dr. Nessan Bermingham

Nessan is an Operating Partner at Khosla Ventures. He is a serial entrepreneur and investor focused on life science companies with an emphasis on nucleic acid editing, novel delivery systems, gene and cell therapy, novel target identification, and data analytics for drug discovery and development. Nessan received his Ph.D. in Molecular Biology from Imperial College London and was a Howard Hughes Associate Fellow at Baylor College of Medicine. In addition to EveryONE Medicines, Nessan serves on the boards of Korro Bio, Stylus Biomedicine, Deep Genomics, Liberate Bio, Ochre Bio, and Focal Medical.